Sarah Murawski, MPAS, discusses how telemedicine can impact the use of chimeric antigen receptor T-cell therapy in patients with cancer at the Association of Community Cancer Centers National Oncology Conference.
Sarah Murawski, MPAS
Articles by Sarah Murawski, MPAS
Latest Updated Articles
Telemedicine Improves Accessibility of CAR T-Cell TherapyNovember 26th 2019